Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Chromosomal differences affect how muscle cells respond to testosterone.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Spironolactone can reduce hair growth in women with hirsutism.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Moxibustion may help improve ovarian function by changing androgen levels.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Excess androgens may cause PCOS, not just be a symptom.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Hair follicle size is mainly influenced by the number of cells and extracellular matrix volume, with cell number having a larger impact.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.